GlassScriptPhysician profile
Evan G Kessler
NPI 1316366404
$1,824.51
in general payments reported to CMS, 2019-2025
12 companies · $661 in 2025
The $661 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $355 · 2022: $150 · 2023: $291 · 2024: $369 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $736 · Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $736.17 |
| Food and Beverage | $584.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $788.48 | 2024-2025 | Micromatrix, Acell, Integra |
| Medtronic Vascular, INC. | $330.00 | 2020 | |
| Tactile Systems Technology INC | $246.43 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Medtronic, INC. | $135.40 | 2023-2024 | Signia, Endurant Iis |
| Penumbra, INC. | $105.00 | 2023 | Ruby Coil |
| Smith+Nephew, INC. | $88.85 | 2023-2024 | Collagenase Santyl, Regranex |
| Abbvie INC. | $30.47 | 2025 | |
| Hydrofera LLC | $24.62 | 2024 | Hydrofera Blue |
| Allergan, INC. | $24.62 | 2020 | |
| Janssen Pharmaceuticals, INC | $21.40 | 2023 | Xarelto |
| Amgen INC. | $14.69 | 2025 | Repatha |
| Cumberland Pharmaceuticals, INC. | $14.55 | 2025 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.